Related Experiment Video
Updated: May 27, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
WNK4 inhibits NCC protein expression through MAPK ERK1/2 signaling pathway
Bo Zhou1, Dexuan Wang, Xiuyan Feng
1Renal Div., Emory Univ. School of Medicine, Atlanta, GA 30322, USA. hcai3@emory.edu
Abstract:
WNK [with no lysine (K)] kinase is a subfamily of serine/threonine kinases. Mutations in two members of this family (WNK1 and WNK4) cause pseudohypoaldosteronism type II featuring hypertension, hyperkalemia, and metabolic acidosis. WNK1 and WNK4 were shown to regulate sodium chloride cotransporter (NCC) activity through phosphorylating SPAK and OSR1. Previous studies including ours have also shown that WNK4 inhibits NCC function and its protein expression. A recent study reported that a phorbol ester inhibits NCC function via activation of extracellular signal-regulated kinase (ERK) 1/2 kinase. In the current study, we investigated whether WNK4 affects NCC via the MAPK ERK1/2 signaling pathway. We found that WNK4 increased ERK1/2 phosphorylation in a dose-dependent manner in mouse distal convoluted tubule (mDCT) cells, whereas WNK4 mutants with the PHA II mutations (E562K and R1185C) lost the ability to increase the ERK1/2 phosphorylation. Hypertonicity significantly increased ERK1/2 phosphorylation in mDCT cells. Knock-down of WNK4 expression by siRNA resulted in a decrease of ERK1/2 phosphorylation. We further showed that WNK4 knock-down significantly increases the cell surface and total NCC protein expressions and ERK1/2 knock-down also significantly increases cell surface and total NCC expression. These data suggest that WNK4 inhibits NCC through activating the MAPK ERK1/2 signaling pathway.
Insights
WNK4 kinase inhibits the sodium chloride cotransporter (NCC) by activating the MAPK ERK1/2 pathway. This finding sheds light on hypertension mechanisms and kidney salt transport regulation.
Area of Science:
- Molecular biology
- Physiology
- Nephrology
Background:
- WNK kinases regulate ion transport, and mutations cause hypertension.
- WNK4 inhibits sodium chloride cotransporter (NCC) function and expression.
- The MAPK ERK1/2 pathway is implicated in NCC regulation.
Purpose of the Study:
- To investigate if WNK4 regulates NCC via the MAPK ERK1/2 signaling pathway.
- To determine the role of WNK4 in ERK1/2 activation and its effect on NCC.
Main Methods:
- Utilized mouse distal convoluted tubule (mDCT) cells.
- Assessed ERK1/2 phosphorylation in response to WNK4 expression and mutants.
- Employed siRNA for WNK4 and ERK1/2 knock-down experiments.
- Quantified cell surface and total NCC protein expression.
Main Results:
- WNK4 dose-dependently increased ERK1/2 phosphorylation in mDCT cells.
- WNK4 mutants associated with pseudohypoaldosteronism type II lost this ability.
- Hypertonicity and WNK4 knock-down affected ERK1/2 phosphorylation.
- WNK4 and ERK1/2 knock-down increased NCC protein expression.
Conclusions:
- WNK4 inhibits NCC function and expression by activating the MAPK ERK1/2 pathway.
- This mechanism is crucial for regulating kidney salt reabsorption and blood pressure.
Related Concept Videos
MAPK Signaling Cascades
Inhibition of Cdk Activity
Inhibition of CDK Activity
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway
